BackBiostax Overview

Biostax Current Cash

Track Biostax's current cash ($-49) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$-49.00
↓ 100.28% YoYΔ $-17475.00 vs prior year quarter

Peer trimmed avg / median

Loading

Biostax Current Cash History

Loading

Biostax vs. peers: Current Cash Comparison

Loading

Biostax Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biostax (BTAX) FAQ

Biostax (BTAX) currently reports a current cash of $-49 as of June 2024. That compares with $17K in the prior-year period — down 100.3% year over year. Use the charts on this page to explore Biostax's current cash history and peer comparisons.

Biostax's current cash decreased from $17K to $-49 — a 100.3% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biostax reported $-49 in current cash as of June 2024. That compares with $17K in the prior-year period — down 100.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $-49, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biostax, and consider following BTAX for alerts when major investors trade the stock.

Biostax is classified in the Healthcare sector. On current cash, it currently shows $-49. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BTAX with unrelated industries.